LIDDS AB (publ) (STO:LIDDS)
Sweden · Delayed Price · Currency is SEK 0.0246
0.00 (0.00%)
Feb 9, 2026, 3:00 PM CET
LIDDS AB Market Cap
LIDDS AB has a market cap or net worth of 3.36 million as of February 11, 2026. Its market cap has decreased by -81.50% in one year.
Market Cap
3.36M
Enterprise Value
1.62M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
0.02
Market Cap Chart
Since July 31, 2014, LIDDS AB's market cap has decreased from 105.45M to 3.36M, a decrease of -96.82%. That is a compound annual growth rate of -25.83%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 9, 2026 | 3.36M | -44.09% |
| Dec 30, 2025 | 6.00M | -56.65% |
| Dec 30, 2024 | 13.85M | 87.96% |
| Dec 29, 2023 | 7.37M | -87.49% |
| Dec 30, 2022 | 58.92M | -81.85% |
| Dec 30, 2021 | 324.60M | -25.82% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| 2cureX AB | 48.95M |
| AcouSort AB | 47.41M |
| Nanologica AB | 36.05M |
| Guard Therapeutics International AB | 35.90M |
| Modus Therapeutics Holding AB | 34.06M |
| Aptahem AB | 18.25M |
| Novakand Pharma AB | 15.75M |
| NanoEcho AB | 15.67M |